GSK-3β and 4E-BP1 phosphorylation levels reached respectively variations of 19% (R1 vs AF) to 54% (R2 vs Mob) and 23% (R1 vs R2) to 39% (R1 vs AF). This evidence concerns the gene GSK3B and atrial fibrillation.